Team ROTOP is back from SNMMI 2025 in New Orleans and feels energized by the global momentum in radiopharmaceuticals.

Team ROTOP – Jens Junker, Felix Roschke, Thomas Gottlieb and Tanmaya Joshi – just returned from SNMMI 2025 in New Orleans. This year, the event brought together nearly 8,000 professionals from across the nuclear medicine and radiopharmaceutical world.

Participating as an exhibitor, we had the opportunity to connect with attendees from the entire radiopharma value chain: from radioisotopes suppliers to manufacturers of finished radiopharmaceuticals and logistics providers — all eager to collaborate and support each other in serving radiopharma needs.

Team ROTOP represented both the CDMO and commercial divisions. Our presence in the radiopharma universe spans more than two decades. A great reflection of our continuously growing footprint in the field was the video teaser of the new production area at the CDMO Center, which was first released in our booth in SNMMI and attracted strong interest. Through this facility, we are offering specialized GMP manufacturing services for clinical-stage targeted radiotherapy programs. We were happy to showcase our infrastructure — including hot cells, cleanrooms, in-house QC, and process development labs — that will allow us to provide flexible, end-to-end CDMO support for clinical programs.

Beyond our recognition as a reliable CDMO partner for diagnostic radiopharmaceuticals, ROTOP team also received increased inquiries around therapeutic isotopes such as Ac-225, Pb-212, and Lu-177 — reinforcing that our commitment to integrating CDMO capabilities for supporting programs in targeted radiotherapeutics is the right path forward.

There was not enough time to finish every conversation, but we have already agreed to reconnect and continue them at EANM in Barcelona later this year.

All in all, SNMMI 2025 was both inspiring and insightful and Team ROTOP is excited for what’s ahead!